ID   Sog9
AC   CVCL_D242
SY   sog9
DR   CCLV; CCLV-RIE 0297
DR   Wikidata; Q54955368
RX   PubMed=7745676;
CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D241 ! Gro2C
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
RX   PubMed=7745676; DOI=10.1128/JVI.69.6.3290-3298.1995; PMCID=PMC189040;
RA   Banfield B.W., Leduc Y., Esford L., Schubert K., Tufaro F.;
RT   "Sequential isolation of proteoglycan synthesis mutants by using
RT   herpes simplex virus as a selective agent: evidence for a
RT   proteoglycan-independent virus entry pathway.";
RL   J. Virol. 69:3290-3298(1995).
//